Related Experiment Videos
Pantoprazole-induced enteropathy - An unexpected cause of seronegative villous atrophy
Tatiana Pacheco1, Pedro Costa-Moreira2, Joana Pinto3
1Gastroenterology, Centro Hospitalar do Tâmega e Sousa, Portugal.
Abstract:
Seronegative villous atrophy (SNVA) presents a diagnostic challenge with a wide range of possible etiologies. This report details a 67-year-old woman who developed chronic watery diarrhea and weight loss following the initiation of pantoprazole for gastroesophageal reflux disease. Duodenal biopsies showed villous atrophy associated with intraepithelial lymphocytosis, while celiac serologies and HLA-DQ2/DQ8 gene testing were negative. Discontinuation of pantoprazole led to the resolution of symptoms, and follow-up biopsies showed normalizes duodenal villous architecture without inflammatory infiltrates. This case represents an association between pantoprazole and the development of seronegative villous atrophy, underscoring the need to consider medications as potential causes of enteropathy.
Related Concept Videos
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Pyloric Obstruction
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction
Gastritis II: Pathophysiology
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...